Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kardia Therapeutics

Out of Business LATEST DEAL TYPE

Developer of a research-stage biotechnology platform designed to focus on the development of cardiac regenerative treatments. The company's platform emphasizes in the areas of myocardial infarction and heart failure by using a three-way related approaches namely, Adult Cardiac Progenitor Cell Therapy, Stem Cell Optimization Technologies and Homing-Growth Factor Therapies, enabling physicians to avail significantly improved health outcomes compared to existing treatments.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 1709 Dryden Road
  • Suite 910
  • Houston, TX 77030
  • United States

+1 (713) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kardia Therapeutics’s full profile, request a free trial.

Kardia Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business Completed Out of Business
4. Early Stage VC Completed Startup
3. Grant 01-Jan-2007 00.000 Completed Startup
2. Grant 01-Jan-2005 $526K Completed Startup
1. Grant 01-Jan-2004 $100K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Kardia Therapeutics Executive Team (2)

Name Title Board
Royal Brompton Founder & Scientific Board Member

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »

Kardia Therapeutics Board Members (1)

Name Representing Role Since Contact
Royal Brompton Kardia Therapeutics Founder & Scientific Board Member 000 0000